HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,717,000 | -5.6% | 115,864 | -6.3% | 0.02% | +4.2% |
Q2 2020 | $1,819,000 | -58.2% | 123,652 | -10.1% | 0.02% | -17.2% |
Q3 2018 | $4,354,000 | +8.0% | 137,559 | +32.6% | 0.03% | +11.5% |
Q2 2018 | $4,030,000 | +69.6% | 103,723 | +20.5% | 0.03% | +36.8% |
Q1 2018 | $2,376,000 | +117.4% | 86,077 | +42.5% | 0.02% | +137.5% |
Q4 2017 | $1,093,000 | – | 60,398 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |